Sources

5 Total Sources

Merck Rises 1.9% on MMR Split Order as Standalone Vaccines May Take 10 Years

Merck Stock Climbs on Presidential Directive for Individual MMR Vaccines, Long Development Expected

pharmaceuticalcommerce.com3d ago

One Vaccine, Three Supply Chains: The Hidden Consequences of Splitting MMR | Pharmaceutical Commerce

Drugmakers uninterested in Donald Trump's order to split up MMR vaccines

FOX 8 Local First8d ago

Separate MMR vaccines Trump wants parents to use don't currently exist in U.S., doctors say

Immunologists and vaccine experts say there's no valid reason to split the MMR vaccine into separate shots, as a new executive order seeks to do. FULL STORY ⬇️